Flibanserin (Addyi): Uses, Interactions & Side Effects
Complete guide to Flibanserin (Addyi) for treating low sexual desire in women.

What is Flibanserin (Addyi)?
Flibanserin is an oral medication prescribed to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. The medication works by balancing neurotransmitter substances in the brain that regulate mood and increase sexual desire. Unlike other sexual enhancement medications, flibanserin addresses the psychological aspects of low libido by working on brain chemistry rather than physical mechanisms. It is marketed under the brand name Addyi and represents an important therapeutic option for women experiencing persistent low sexual desire that causes significant distress.
How Does Flibanserin Work?
Flibanserin operates through a unique mechanism of action that differentiates it from other sexual dysfunction treatments. The medication functions as a serotonin agonist and dopamine agonist while simultaneously acting as a 5-HT1A receptor modulator. This complex pharmacological profile allows flibanserin to balance brain chemicals involved in sexual desire regulation. By modulating these neurotransmitter systems, the medication helps restore sexual desire to the woman’s previous baseline and reduces the emotional distress associated with low libido. The drug is specifically designed for premenopausal women and has demonstrated effectiveness in clinical trials involving thousands of patients.
Uses and Indications
Flibanserin is primarily indicated for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. HSDD is characterized by persistent or recurrent deficiency of sexual fantasies, thoughts, or desire for sexual activity that causes marked personal distress or interpersonal difficulties. The medication increases sexual desire and reduces distress related to low libido or lack of sexual desire. It may also be used for other purposes as determined by healthcare providers. Women considering this medication should discuss with their healthcare provider whether they have acquired, generalized HSDD and whether the condition is causing significant distress in their lives.
Dosage and Administration
Standard Dosing
The recommended dose of flibanserin for adults is 100 milligrams (mg) taken orally once daily at bedtime. This dosage has been established through clinical trials as the optimal therapeutic dose balancing efficacy with tolerability. The medication should be taken exactly as directed by your healthcare provider, and patients should not adjust their dosage without medical guidance.
Administration Instructions
Flibanserin must be taken by mouth with water only at bedtime. Taking this medication at times other than bedtime significantly increases the risk of low blood pressure, fainting, accidental injury, and excessive sleepiness. The bedtime administration timing is critical to the medication’s safety profile and effectiveness. Patients should establish a consistent routine of taking the medication at the same time each evening to maximize therapeutic benefits.
Missed Dose Instructions
If you miss your dose at bedtime, simply skip the missed dose and resume your regular dosing schedule the following night. Do not take the missed dose the next morning and do not double your next dose to make up for a missed dose. This approach helps prevent accidental overdosing and maintains safe medication levels in your system.
Important Precautions and Contraindications
Grapefruit Interaction
Flibanserin should never be taken with grapefruit juice, and grapefruit consumption should be avoided entirely while taking this medication. Grapefruit and grapefruit juice can significantly change the amount of flibanserin absorbed by the body, potentially increasing drug levels to dangerous concentrations and exacerbating side effects. This interaction is particularly important because elevated flibanserin levels can increase the risk of hypotension and syncope.
Alcohol Consumption
Alcohol consumption requires careful attention when taking flibanserin. If you consume one or two standard alcoholic drinks, wait at least two hours before taking your bedtime dose of flibanserin. However, if you have consumed three or more standard alcoholic drinks in the evening, do not take your bedtime dose at all. Additionally, after taking flibanserin at bedtime, do not drink alcohol until the next day. This precaution is essential because alcohol can significantly increase dizziness, drowsiness, and the risk of low blood pressure or fainting spells when combined with flibanserin.
Driving and Operating Machinery
Flibanserin may cause drowsiness, dizziness, or lightheadedness. Patients should not drive, operate machinery, or engage in activities requiring mental alertness for at least six hours after taking the medication and until they understand how the drug affects them individually. This precaution applies even if you feel alert, as the medication’s effects can persist longer than expected.
Position Changes
Do not stand up or sit up quickly after taking flibanserin, as this can increase the risk of dizziness or fainting spells. Rise slowly from a seated or lying position to allow your body to adjust and maintain proper blood pressure regulation. This simple precaution can significantly reduce the occurrence of orthostatic hypotension.
Side Effects
Common Side Effects
The most frequently reported side effects of flibanserin include dizziness, drowsiness or excessive sleepiness, fatigue or unusual tiredness, and sweating. These effects are generally mild to moderate and often improve with continued use as the body adjusts to the medication. Some patients may experience blurred vision, confusion, or fainting, particularly when changing positions quickly.
Less Common Side Effects
Less frequently reported adverse effects include a sensation of spinning or constant movement of the self or surroundings (vertigo), constipation, dry mouth, nervousness, and menstrual irregularities such as earlier onset or prolonged bleeding. Early menstruation lasting longer than usual may occur in some women taking this medication.
Rare and Serious Side Effects
Rare but serious side effects requiring immediate medical attention include chest tightness, difficulty swallowing, cough, fast heartbeat, and severe allergic reactions including anaphylaxis and angioedema. Additionally, bloating, fever, nausea, severe cramping, and abdominal pain have been reported rarely. Swelling of the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals warrants immediate emergency medical evaluation.
Central Nervous System Depression
One significant safety concern is central nervous system (CNS) depression, with approximately 21 percent of clinical trial subjects experiencing symptoms consistent with CNS depression, including dizziness, somnolence, nausea, and fatigue. Accidental injuries associated with CNS depression occurred more than twice as often in flibanserin-treated patients compared to placebo-treated patients in clinical studies. This finding underscores the importance of taking the medication only at bedtime and avoiding alcohol.
Drug Interactions
Flibanserin has several important drug interactions that patients and healthcare providers must carefully consider. The medication should not be taken with certain antifungal medications, as these can significantly increase flibanserin blood levels and the risk of adverse effects. Similarly, oral contraceptives, triptans (migraine medications), and many other medications can exacerbate flibanserin’s adverse effects. The maximum tolerated dose of flibanserin is 250 mg, which is relatively close to the standard 100 mg daily dose, leaving limited room for dose adjustments when drug interactions occur.
Patients taking any other medications should inform their healthcare provider before starting flibanserin. Never combine flibanserin with medications that increase hypotension risk without explicit medical clearance, as this combination can lead to severe drops in blood pressure and fainting.
Medical Conditions Requiring Disclosure
Before starting flibanserin, inform your healthcare provider if you have any of the following conditions: liver disease or impairment, kidney disease, heart disease, low blood pressure, mental health disorders including depression or bipolar disorder, bleeding disorders, or if you are pregnant or planning to become pregnant. Additionally, disclose any history of allergic reactions to flibanserin or any other medications. Women with certain medical conditions may not be appropriate candidates for flibanserin therapy.
Effectiveness and Timeline
Clinical trials demonstrate that at least 50 percent of women experience a meaningful response to flibanserin therapy. However, improvement is not immediate. Patients should continue taking the medication consistently and visit their healthcare provider for regular progress checks. If symptoms do not begin improving after eight weeks of consistent use, or if symptoms worsen during treatment, patients should consult with their healthcare provider to discuss alternative options. Those not responding to the medication can discontinue therapy without experiencing withdrawal effects.
Important Safety Information
Medication Guide
Flibanserin should come with a comprehensive Medication Guide. Patients are strongly encouraged to read and carefully follow all instructions in this guide. Ask your pharmacist or healthcare provider to clarify any questions about proper use, side effects, or precautions.
For Healthcare Providers Only
Screening for HSDD may be accomplished using simple office screeners such as the Decreased Sexual Desire Screener during annual women’s health visits. Not all women with sexual dysfunction are candidates for flibanserin; however, many are appropriate candidates, and shared decision-making can identify suitable patients for whom flibanserin represents an excellent therapeutic option.
Reporting Side Effects
Patients experiencing side effects should report them to their healthcare team as soon as possible. Side effects can also be reported directly to the U.S. Food and Drug Administration (FDA) at 1-800-FDA-1088. This reporting helps monitor medication safety and identify any emerging concerns with the drug.
Frequently Asked Questions
Q: What is hypoactive sexual desire disorder (HSDD)?
A: HSDD is a medical condition characterized by persistent or recurrent deficiency of sexual fantasies, thoughts, or desire for sexual activity that causes marked personal distress or interpersonal difficulties. It affects premenopausal women and is distinct from other sexual dysfunctions.
Q: How long does it take for flibanserin to work?
A: Improvement in sexual desire typically begins within several weeks, though patients should continue taking the medication consistently. Healthcare providers recommend assessing effectiveness after eight weeks of regular use before determining if the medication is working adequately.
Q: Can I take flibanserin with birth control pills?
A: Oral contraceptives can exacerbate flibanserin’s adverse effects. Discuss with your healthcare provider about the safety of combining these medications, as individual circumstances vary.
Q: What should I do if I miss a dose?
A: If you miss your bedtime dose, simply skip the missed dose and resume your regular dosing schedule the next evening. Never double your dose to compensate for a missed dose.
Q: Is flibanserin safe for all women?
A: Flibanserin is specifically approved for premenopausal women with HSDD. It is not recommended for children, and certain medical conditions may contraindicate its use. Discuss your complete medical history with your healthcare provider.
Q: Can I share my flibanserin prescription with others?
A: No. This medication is prescribed specifically for you. Do not share this medicine with any other person, even if they have similar symptoms, as it may be inappropriate or dangerous for them.
Q: How effective is flibanserin?
A: Clinical studies show that approximately 50 percent of women treated with flibanserin experience meaningful improvements in sexual desire. For those who do not respond, discontinuing the medication is an option.
Q: What are the most common side effects I might experience?
A: The most common side effects include dizziness, drowsiness, fatigue, and sweating. These effects are often manageable and may diminish over time as your body adjusts to the medication.
References
- Flibanserin (Addyi): Uses, Interactions & Side Effects — Cleveland Clinic. 2024. https://my.clevelandclinic.org/health/drugs/18608-flibanserin-oral-tablets
- Flibanserin (oral route) – Side effects & dosage — Mayo Clinic. 2024. https://www.mayoclinic.org/drugs-supplements/flibanserin-oral-route/description/drg-20152672
- Taking Sides: Should ob/gyns prescribe flibanserin for their patients? — Contemporary OB/GYN. 2024. https://www.contemporaryobgyn.net/view/taking-sides-should-obgyns-prescribe-flibanserin-their-patients
- Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index — National Center for Biotechnology Information. 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9780775/
- Sexual dysfunction in women: Can we talk about it? — Cleveland Clinic Journal of Medicine. 2015. https://www.ccjm.org/content/84/5/367
Read full bio of Sneha Tete
















